Acinar cell carcinoma of the pancreas in the united states: Prognostic factors and comparison to ductal adenocarcinoma

C. Schmidt, Jesus Manuel Matos, David J. Bentrem, Mark S. Talamonti, Keith D. Lillemoe, Karl Y. Bilimoria

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Pancreatic acinar cell carcinoma (ACC) is a rare tumor with poorly defined prognosis. Our objective was to compare a large population of patients with ACC to pancreatic ductal cell adenocarcinoma (DCC) in order to determine distinguishing characteristics and to assess survival. Patients were identified from the National Cancer Database. Regression methods were used to identify differences between ACC and DCC and to identify predictors of survival for resected ACC. Eight hundred sixty-five patients with ACC were identified. Median tumor size was 6.9 cm (vs. 4.6 cm DCC); 32.1% had nodal metastases (vs. 48.0% DCC); and 47% had high-grade tumors (vs. 37.3% DCC). Resection margins were R0 77.3%, R1 13.7%, and R2 9.0%. Patients with ACC were more likely to be male, white, and have larger tumor size, no nodal involvement, or pancreatic tail tumors. Stage-specific 5-year survival was significantly better for resected ACC vs. DCC Stage I: 52.4% vs. 28.4%, II: 40.2% vs. 9.8%, III: 22.8% vs. 6.8%, and IV: 17.2% vs. 2.8%. On multivariable analysis, age < 65, well-differentiated tumors, and negative resection margins were independent prognostic factors for ACC. ACC carries a better prognosis than DCC. Aggressive surgical resection with negative margins is associated with long-term survival in these more favorable pancreatic cancers.

Original languageEnglish
Pages (from-to)2078-2086
Number of pages9
JournalJournal of Gastrointestinal Surgery
Volume12
Issue number12
DOIs
StatePublished - Dec 2008

Fingerprint

Acinar Cell Carcinoma
Pancreas
Adenocarcinoma
Neoplasms
Survival
Pancreatic Neoplasms
Databases
Neoplasm Metastasis

Keywords

  • Acinar cell carcinoma
  • National Cancer Data Base
  • Pancreatectomy
  • Pancreatic adenocarcinoma
  • Resection
  • Surgery

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Cite this

Acinar cell carcinoma of the pancreas in the united states : Prognostic factors and comparison to ductal adenocarcinoma. / Schmidt, C.; Matos, Jesus Manuel; Bentrem, David J.; Talamonti, Mark S.; Lillemoe, Keith D.; Bilimoria, Karl Y.

In: Journal of Gastrointestinal Surgery, Vol. 12, No. 12, 12.2008, p. 2078-2086.

Research output: Contribution to journalArticle

Schmidt, C. ; Matos, Jesus Manuel ; Bentrem, David J. ; Talamonti, Mark S. ; Lillemoe, Keith D. ; Bilimoria, Karl Y. / Acinar cell carcinoma of the pancreas in the united states : Prognostic factors and comparison to ductal adenocarcinoma. In: Journal of Gastrointestinal Surgery. 2008 ; Vol. 12, No. 12. pp. 2078-2086.
@article{6323176532124323a6810cd8a1c1dab0,
title = "Acinar cell carcinoma of the pancreas in the united states: Prognostic factors and comparison to ductal adenocarcinoma",
abstract = "Pancreatic acinar cell carcinoma (ACC) is a rare tumor with poorly defined prognosis. Our objective was to compare a large population of patients with ACC to pancreatic ductal cell adenocarcinoma (DCC) in order to determine distinguishing characteristics and to assess survival. Patients were identified from the National Cancer Database. Regression methods were used to identify differences between ACC and DCC and to identify predictors of survival for resected ACC. Eight hundred sixty-five patients with ACC were identified. Median tumor size was 6.9 cm (vs. 4.6 cm DCC); 32.1{\%} had nodal metastases (vs. 48.0{\%} DCC); and 47{\%} had high-grade tumors (vs. 37.3{\%} DCC). Resection margins were R0 77.3{\%}, R1 13.7{\%}, and R2 9.0{\%}. Patients with ACC were more likely to be male, white, and have larger tumor size, no nodal involvement, or pancreatic tail tumors. Stage-specific 5-year survival was significantly better for resected ACC vs. DCC Stage I: 52.4{\%} vs. 28.4{\%}, II: 40.2{\%} vs. 9.8{\%}, III: 22.8{\%} vs. 6.8{\%}, and IV: 17.2{\%} vs. 2.8{\%}. On multivariable analysis, age < 65, well-differentiated tumors, and negative resection margins were independent prognostic factors for ACC. ACC carries a better prognosis than DCC. Aggressive surgical resection with negative margins is associated with long-term survival in these more favorable pancreatic cancers.",
keywords = "Acinar cell carcinoma, National Cancer Data Base, Pancreatectomy, Pancreatic adenocarcinoma, Resection, Surgery",
author = "C. Schmidt and Matos, {Jesus Manuel} and Bentrem, {David J.} and Talamonti, {Mark S.} and Lillemoe, {Keith D.} and Bilimoria, {Karl Y.}",
year = "2008",
month = "12",
doi = "10.1007/s11605-008-0705-6",
language = "English",
volume = "12",
pages = "2078--2086",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "12",

}

TY - JOUR

T1 - Acinar cell carcinoma of the pancreas in the united states

T2 - Prognostic factors and comparison to ductal adenocarcinoma

AU - Schmidt, C.

AU - Matos, Jesus Manuel

AU - Bentrem, David J.

AU - Talamonti, Mark S.

AU - Lillemoe, Keith D.

AU - Bilimoria, Karl Y.

PY - 2008/12

Y1 - 2008/12

N2 - Pancreatic acinar cell carcinoma (ACC) is a rare tumor with poorly defined prognosis. Our objective was to compare a large population of patients with ACC to pancreatic ductal cell adenocarcinoma (DCC) in order to determine distinguishing characteristics and to assess survival. Patients were identified from the National Cancer Database. Regression methods were used to identify differences between ACC and DCC and to identify predictors of survival for resected ACC. Eight hundred sixty-five patients with ACC were identified. Median tumor size was 6.9 cm (vs. 4.6 cm DCC); 32.1% had nodal metastases (vs. 48.0% DCC); and 47% had high-grade tumors (vs. 37.3% DCC). Resection margins were R0 77.3%, R1 13.7%, and R2 9.0%. Patients with ACC were more likely to be male, white, and have larger tumor size, no nodal involvement, or pancreatic tail tumors. Stage-specific 5-year survival was significantly better for resected ACC vs. DCC Stage I: 52.4% vs. 28.4%, II: 40.2% vs. 9.8%, III: 22.8% vs. 6.8%, and IV: 17.2% vs. 2.8%. On multivariable analysis, age < 65, well-differentiated tumors, and negative resection margins were independent prognostic factors for ACC. ACC carries a better prognosis than DCC. Aggressive surgical resection with negative margins is associated with long-term survival in these more favorable pancreatic cancers.

AB - Pancreatic acinar cell carcinoma (ACC) is a rare tumor with poorly defined prognosis. Our objective was to compare a large population of patients with ACC to pancreatic ductal cell adenocarcinoma (DCC) in order to determine distinguishing characteristics and to assess survival. Patients were identified from the National Cancer Database. Regression methods were used to identify differences between ACC and DCC and to identify predictors of survival for resected ACC. Eight hundred sixty-five patients with ACC were identified. Median tumor size was 6.9 cm (vs. 4.6 cm DCC); 32.1% had nodal metastases (vs. 48.0% DCC); and 47% had high-grade tumors (vs. 37.3% DCC). Resection margins were R0 77.3%, R1 13.7%, and R2 9.0%. Patients with ACC were more likely to be male, white, and have larger tumor size, no nodal involvement, or pancreatic tail tumors. Stage-specific 5-year survival was significantly better for resected ACC vs. DCC Stage I: 52.4% vs. 28.4%, II: 40.2% vs. 9.8%, III: 22.8% vs. 6.8%, and IV: 17.2% vs. 2.8%. On multivariable analysis, age < 65, well-differentiated tumors, and negative resection margins were independent prognostic factors for ACC. ACC carries a better prognosis than DCC. Aggressive surgical resection with negative margins is associated with long-term survival in these more favorable pancreatic cancers.

KW - Acinar cell carcinoma

KW - National Cancer Data Base

KW - Pancreatectomy

KW - Pancreatic adenocarcinoma

KW - Resection

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=57049118474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57049118474&partnerID=8YFLogxK

U2 - 10.1007/s11605-008-0705-6

DO - 10.1007/s11605-008-0705-6

M3 - Article

C2 - 18836784

AN - SCOPUS:57049118474

VL - 12

SP - 2078

EP - 2086

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 12

ER -